Search by Drug Name or NDC

    NDC 00363-4150-08 Severe Cold and Flu Relief 325; 10; 200; 5 mg/15mL; mg/15mL; mg/15mL; mg/15mL Details

    Severe Cold and Flu Relief 325; 10; 200; 5 mg/15mL; mg/15mL; mg/15mL; mg/15mL

    Severe Cold and Flu Relief is a ORAL LIQUID in the HUMAN OTC DRUG category. It is labeled and distributed by Walgreens. The primary component is ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 00363-4150
    Product ID 0363-4150_6963a3b5-d61d-43e2-ab68-7a9574a61d4a
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Severe Cold and Flu Relief
    Proprietary Name Suffix Daytime
    Non-Proprietary Name Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride
    Product Type HUMAN OTC DRUG
    Dosage Form LIQUID
    Route ORAL
    Active Ingredient Strength 325; 10; 200; 5
    Active Ingredient Units mg/15mL; mg/15mL; mg/15mL; mg/15mL
    Substance Name ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name Walgreens
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through 2024-12-31

    Package

    NDC 00363-4150-08 (00363415008)

    NDC Package Code 0363-4150-08
    Billing NDC 00363415008
    Package 237 mL in 1 BOTTLE, PLASTIC (0363-4150-08)
    Marketing Start Date 2020-07-30
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL c89200b6-4adb-452e-b931-07f631dad641 Details

    Revised: 9/2022